MRK - Merck Keytruda combo fails in late-stage trial for uterine cancer
2023-12-08 07:23:58 ET
More on Merck
- Merck & Co., Inc. (MRK) Management Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Merck Will Keep Your Retirement Income Healthy
- Merck: Not The Time To Be Adding
- Merck halts lung cancer trial for Keytruda combo after failure in main goal
- Merck coformulation fails to meet key goal in lung cancer trial
For further details see:
Merck Keytruda combo fails in late-stage trial for uterine cancer